PROVO, Utah - Nu Skin Enterprises, Inc. (NYSE: NUS), a global beauty and wellness company, has announced a quarterly cash dividend of $0.06 per share. The dividend is scheduled to be paid on September 11, 2024, to shareholders who are on record as of August 30, 2024.
Nu Skin Enterprises has a diverse portfolio that includes Nu Skin personal care, Pharmanex nutrition, and ageLOC anti-aging brands. The company, which has been conducting scientific research for over 40 years, operates in nearly 50 markets worldwide. Rhyz Inc., their strategic investment arm, focuses on fostering innovation across beauty, wellness, and lifestyle sectors.
InvestingPro Insights
In light of Nu Skin Enterprises' recent dividend announcement, a look at the company's financial health and market performance can provide investors with a broader perspective. According to InvestingPro data, Nu Skin has a market capitalization of approximately $513.56 million, with a Price to Earnings (P/E) ratio of -155.22, reflecting challenges in the company's profitability over the last twelve months. However, the adjusted P/E ratio for the same period stands at a more favorable 9.57, suggesting better earnings potential moving forward.
InvestingPro Tips highlight that Nu Skin has notably raised its dividend for 23 consecutive years, signifying a long-term commitment to shareholder returns. This is complemented by the company's impressive gross profit margin of 71.87% over the last twelve months, which speaks to its pricing power and cost control measures. Additionally, investors should note that analysts predict the company will be profitable this year, which could signal a turnaround from the previous period's performance.
While the data points to some areas of strength, it is also important to recognize that analysts anticipate a sales decline in the current year. This could be a factor for investors to consider as they assess the sustainability of dividend payments and the company's growth trajectory. For a more comprehensive analysis, there are over ten additional InvestingPro Tips available, which can offer deeper insights into Nu Skin's financials and market positioning.
The recent performance of Nu Skin's stock price also warrants attention. Over the past year, the price has decreased significantly, reflecting a 57.16% decline. This could present a potential opportunity for investors looking for an entry point into a company that has a history of dividend reliability and a strong gross profit margin. For those considering an investment, the fair value estimates from analysts and InvestingPro suggest a potential upside from the previous close of $10.49, with targets of $12.5 and $15.51 respectively.
As the company prepares to distribute its upcoming dividend, prospective and current investors can leverage these insights and the additional tips available on InvestingPro to make informed decisions about their investment in Nu Skin Enterprises.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.